MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial studies how well a magnetic resonance imaging (MRI)-based machine learning approach (i.e., artificial intelligence \[AI\]) works as compared to radiologist MRI readings in detecting prostate cancer. One of the current methods used to help diagnose possible prostate cancer is performing a prostate MRI. An MRI uses a magnetic field to take pictures of the body. The MRI images are examined by a radiologist. If a suspicious area is seen in the MRI, the radiologist assigns it a PIRADS score. This stands for Prostate Imaging Reporting and Data System. The PIRADS score is used to report how likely it is that a suspicious area in the prostate is cancer. The AI system has been developed also to be able to analyze prostate MRI images and detect suspicious areas in the prostate that may be cancer. The AI system's ability to diagnose aggressive prostate cancer may be similar to detection performed by experienced radiologists using the standard PIRADS system of analyzing prostate MRI.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjenci poddawani biopsji prostaty (pobraniu próbki tkanki) jako standardowe leczenie
- •Pacjenci, którzy przeszli badanie MRI prostaty w ciągu roku przed biopsją
- •Pacjenci zgodzili się uczestniczyć w badaniu
- •Pacjenci poddawani operacyjnemu usunięciu prostaty z powodu raka
- •Pacjenci, którzy przeszli badanie MRI prostaty w ciągu roku przed operacją
✗ Disqualifies
- •Pacjenci z przeszłością raka prostaty
- •Pacjenci po chirurgicznym leczeniu łagodnego powiększenia prostaty
- •Pacjenci poniżej 20 lat
- •Pacjenci, którzy już przechodzili wcześniej biopsję prostaty
- •Badanie MRI bez standardowej oceny (skali PIRADS)
- •Badanie MRI niskiego jakości lub zniekształcone
- •Pacjenci otrzymujący hormonoterapię przed operacją usunięcia prostaty
Simplified criteria — AI translation
Trial details
- Minimum age
- 20 Years
- Last updated (source)
- September 1, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
USC / Norris Comprehensive Cancer Center
Los Angeles, United States
Trial contact
Ileana Aldana
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/2/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.